Terms: = Lung cancer AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292 AND Prognosis
28 results:
1. A Phase II Study of High-Flow Nasal Cannula for Relieving Dyspnea in Advanced cancer Patients.
Takase E; Akamatsu H; Teraoka S; Nakaguchi K; Tanaka M; Kaki T; Furuta K; Sato K; Murakami E; Sugimoto T; Shibaki R; Fujimoto D; Hayata A; Tokudome N; Ozawa Y; Koh Y; Nakanishi M; Kanai K; Shimokawa T; Yamamoto N
J Pain Symptom Manage; 2024 Mar; 67(3):204-211.e1. PubMed ID: 37992848
[TBL] [Abstract] [Full Text] [Related]
2. METTL3-induced lncRNA GBAP1 promotes hepatocellular carcinoma progression by activating BMP/SMAD pathway.
Liu R; Yin G; Tuo H; Guo Y; Zhu Y; Zhang L; Yang W; Liu Q; Wang Y
Biol Direct; 2023 Sep; 18(1):53. PubMed ID: 37658413
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic roles of hematological indicators for the efficacy and prognosis of immune checkpoint inhibitors in patients with advanced tumors: a retrospective cohort study.
Zheng F; Meng Q; Zhang L; Chen J; Zhao L; Zhou Z; Liu Y
World J Surg Oncol; 2023 Jul; 21(1):198. PubMed ID: 37420219
[TBL] [Abstract] [Full Text] [Related]
4. Nicotinamide adenine dinucleotide kinase promotes lymph node metastasis of NSCLC via activating ID1 expression through BMP pathway.
Zeng Z; Gao J; Chen T; Zhang Z; Li M; Fan Q; Liu G; Li X; Li Z; Zhong C; Yao F; Sun L; Deng Y; Li M
Int J Biol Sci; 2023; 19(10):3184-3199. PubMed ID: 37416767
[TBL] [Abstract] [Full Text] [Related]
5. Development and Validation of a Prognostic Model to Predict Overall Survival for lung Adenocarcinoma: A Population-Based Study From the SEER Database and the Chinese Multicenter lung cancer Database.
Wang Z; Hu F; Chang R; Yu X; Xu C; Liu Y; Wang R; Chen H; Liu S; Xia D; Chen Y; Ge X; Zhou T; Zhang S; Pang H; Fang X; Zhang Y; Li J; Hu K; Cai Y
Technol Cancer Res Treat; 2022; 21():15330338221133222. PubMed ID: 36412085
[No Abstract] [Full Text] [Related]
6. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma.
Pan J; Huang Z; Lin H; Cheng W; Lai J; Li J
BMC Cancer; 2022 Nov; 22(1):1132. PubMed ID: 36333719
[TBL] [Abstract] [Full Text] [Related]
7. Current cancer burden in China: epidemiology, etiology, and prevention.
Maomao C; He L; Dianqin S; Siyi H; Xinxin Y; Fan Y; Shaoli Z; Changfa X; Lin L; Ji P; Wanqing C
Cancer Biol Med; 2022 Aug; 19(8):1121-38. PubMed ID: 36069534
[TBL] [Abstract] [Full Text] [Related]
8. miR-657 Targets SRCIN1 via the Slug Pathway to Promote NSCLC Tumor Growth and EMT Induction.
Zhang Y; Yuan J; Guo M; Xiang R; Wang X; Xie T; Zhuang X; Li Q; Lai Q
Dis Markers; 2022; 2022():4842454. PubMed ID: 36033827
[TBL] [Abstract] [Full Text] [Related]
9. A predictive model based on liquid biopsy for non-small cell lung cancer to assess patient's prognosis: Development and application.
Gu T; Ren J; Hu Z; Wei Y; Huang J
Tissue Cell; 2022 Aug; 77():101854. PubMed ID: 35752028
[TBL] [Abstract] [Full Text] [Related]
10. Limited resection for stage IA radiologically invasive lung cancer: a real-world nationwide database study.
Soh J; Toyooka S; Shintani Y; Okami J; Ito H; Ohtsuka T; Mori T; Watanabe SI; Asamura H; Chida M; Endo S; Nakanishi R; Kadokura M; Suzuki H; Miyaoka E; Yoshino I; Date H;
Eur J Cardiothorac Surg; 2022 Jun; 62(1):. PubMed ID: 35678584
[TBL] [Abstract] [Full Text] [Related]
11. Evaluation of the prevalence of metachronous second primary malignancies in hypopharyngeal carcinoma and their effect on outcomes.
Luo X; Huang X; Liu S; Wang X; Luo J; Xiao J; Wang K; Qu Y; Chen X; Zhang Y; Wang J; Zhang J; Xu G; Gao L; Wu R; Yi J
Cancer Med; 2022 Feb; 11(4):1059-1067. PubMed ID: 35080148
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy and tolerability of vismodegib treatment in locally advanced and metastatic basal cell carcinoma: Retrospective real-life data.
Gürbüz M; Doğan İ; Akkuş E; Ermiş H; Utkan G; Vatansever S; Taş F
Dermatol Ther; 2021 Nov; 34(6):e15122. PubMed ID: 34478210
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic Value of Uncertain Resection for Overall Survival in Non-small Cell lung cancer.
Kadomatsu Y; Nakamura S; Ueno H; Goto M; Ozeki N; Fukumoto K; Fukui T; Suzuki Y; Chen-Yoshikawa TF
Ann Thorac Surg; 2022 Oct; 114(4):1262-1268. PubMed ID: 34474024
[TBL] [Abstract] [Full Text] [Related]
14. [Survival benefit of primary site surgery acquired by stage Ⅳ non-small cell lung cancer: a retrospective study based on seer database].
Li L; Xu B; Wu J; Song QB
Zhonghua Zhong Liu Za Zhi; 2021 Mar; 43(3):335-344. PubMed ID: 33752315
[No Abstract] [Full Text] [Related]
15. Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors.
Sander MS; Stukalin I; Vallerand IA; Goutam S; Ewanchuk BW; Meyers DE; Pabani A; Morris DG; Heng DYC; Cheng T
Cancer Med; 2021 Apr; 10(8):2618-2626. PubMed ID: 33724676
[TBL] [Abstract] [Full Text] [Related]
16. [Prognostic analysis of definitive radiotherapy for early esophageal carcinoma(T1-2N0M0): a multi-center retrospective study of Jing-Jin-ji Esophageal and Esophagogastric cancer Radiotherapy Oncology Group].
Lu N; Wang X; Li C; Wang L; Chen JQ; Zhang WC; Wang XM; Ge XL; Shen WB; Hu MM; Yuan QQ; Xu YG; Hao CL; Zhou ZG; Qie S; Xiao ZF; Zhu SC; Han C; Qiao XY; Pang QS; Wang P; Zhao YD; Sun XC; Zhang KX; Li L; Li GF; Liu ML; Wang YD
Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):139-144. PubMed ID: 32135649
[No Abstract] [Full Text] [Related]
17. Clinicopathologic features of anaplastic myxopapillary ependymomas.
Lee JC; Sharifai N; Dahiya S; Kleinschmidt-DeMasters BK; Rosenblum MK; Reis GF; Samuel D; Siongco AM; Santi M; Storm PB; Ferris SP; Bollen AW; Pekmezci M; Solomon DA; Tihan T; Perry A
Brain Pathol; 2019 Jan; 29(1):75-84. PubMed ID: 30417460
[TBL] [Abstract] [Full Text] [Related]
18. Clinical Significance of 4L Lymph Node Dissection in Left lung cancer.
Wang YN; Yao S; Wang CL; Li MS; Sun LN; Yan QN; Tang SW; Zhang ZF
J Clin Oncol; 2018 Oct; 36(29):2935-2942. PubMed ID: 30148659
[TBL] [Abstract] [Full Text] [Related]
19. Adjuvant chemotherapy for elderly patients with non-small-cell lung cancer.
Yamanashi K; Okumura N; Yamamoto Y; Takahashi A; Nakashima T; Matsuoka T; Kameyama K
Asian Cardiovasc Thorac Ann; 2017 Jun; 25(5):371-377. PubMed ID: 28592139
[TBL] [Abstract] [Full Text] [Related]
20. Is the prognosis of occult N2 disease similar to that of positive positron emission tomography-computed tomography (PET/CT) scan single-station N2 disease in patients with non-small cell lung cancer treated by surgical resection?
Honguero Martínez AF; García Jiménez MD; García Vicente A; Genovés Crespo M; Rodríguez Ortega CR; Lázaro Sahuquillo M; Soriano Castrejón ÁM; León Atance P
Rev Esp Med Nucl Imagen Mol; 2017; 36(6):350-355. PubMed ID: 28552624
[TBL] [Abstract] [Full Text] [Related]
[Next]
